{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:12:15Z","timestamp":1787994735650,"version":"build-2784847793"},"reference-count":37,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Friedrich-Loeffler-Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Ebola virus (EBOV) causes hemorrhagic fever in humans with high case fatality rates. In the past, a number of recombinant EBOVs expressing different reporters from additional transcription units or as fusion proteins have been rescued. These viruses are important tools for the study of EBOV, and their uses include high throughput screening approaches, the analysis of intercellular localization of viral proteins and of tissue distribution of viruses, and the study of pathogenesis in vivo. However, they all show, at least in vivo, attenuation compared to wild type virus, and the basis of this attenuation is only poorly understood. Unfortunately, rescue of these viruses is a lengthy and not always successful process, and working with them is restricted to biosafety level (BSL)-4 laboratories, so that the search for non-attenuated reporter-expressing EBOVs remains challenging. However, several life cycle modeling systems have been developed to mimic different aspects of the filovirus life cycle under BSL-1 or -2 conditions, but it remains unclear whether these systems can be used to predict the viability and possible attenuation of recombinant EBOVs. To address this question, we systematically fused N- or C-terminally either a flag-HA tag or a green fluorescent protein (GFP) to different EBOV proteins, and analyzed the impact of these additions with respect to protein function in life cycle modeling systems. Based on these results, selected recombinant EBOVs encoding these tags\/proteins were then rescued and characterized for a possible attenuation in vitro, and results compared with data from the life cycle modeling systems. While the results for the small molecular tags showed mostly good concordance, GFP-expressing viruses were more attenuated than expected based on the results from the life cycle modeling system, demonstrating a limitation of these systems and emphasizing the importance of work with infectious virus. Nevertheless, life cycle modeling system remain useful tools to exclude non-viable tagging strategies.<\/jats:p>","DOI":"10.3390\/v14051044","type":"journal-article","created":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T09:48:22Z","timestamp":1652608102000},"page":"1044","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of Life Cycle Modeling Systems as Prediction Tools for a Possible Attenuation of Recombinant Ebola Viruses"],"prefix":"10.3390","volume":"14","author":[{"given":"Bianca S.","family":"Bodmer","sequence":"first","affiliation":[{"name":"Institute for Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, 17493 Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5829-6305","authenticated-orcid":false,"given":"Thomas","family":"Hoenen","sequence":"additional","affiliation":[{"name":"Institute for Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, 17493 Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41579-019-0187-4","article-title":"New filovirus disease classification and nomenclature","volume":"17","author":"Kuhn","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/jgv.0.001252","article-title":"ICTV Virus Taxonomy Profile: Filoviridae","volume":"100","author":"Kuhn","year":"2019","journal-title":"J. Gen. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/21505594.2021.1898169","article-title":"Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity","volume":"12","author":"Yamaoka","year":"2021","journal-title":"Virulence"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-018-0630-0","article-title":"Cryo-EM structure of the Ebola virus nucleoprotein-RNA complex at 3.6\u2014A resolution","volume":"563","author":"Sugita","year":"2018","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/JVI.73.3.2333-2342.1999","article-title":"Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems","volume":"73","author":"Muhlberger","year":"1999","journal-title":"J. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.02349-05","article-title":"Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation","volume":"80","author":"Reid","year":"2006","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1128\/JVI.01272-14","article-title":"A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity","volume":"88","author":"Watt","year":"2014","journal-title":"J. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/JVI.76.10.4855-4865.2002","article-title":"Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP","volume":"76","author":"Noda","year":"2002","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Moller-Tank, S., and Maury, W. (2015). Ebola virus entry: A curious and complex series of events. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004731"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104569","DOI":"10.1016\/j.antiviral.2019.104569","article-title":"High-throughput screening for negative-stranded hemorrhagic fever viruses using reverse genetics","volume":"170","author":"Wendt","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.10.048","article-title":"Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening","volume":"332","author":"Towner","year":"2005","journal-title":"Virology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2011.10.011","article-title":"Identification of an antioxidant small-molecule with broad-spectrum antiviral activity","volume":"93","author":"Panchal","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13073-018-0570-1","article-title":"A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle","volume":"10","author":"Martin","year":"2018","journal-title":"Genome Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11779","DOI":"10.1128\/JVI.01525-12","article-title":"Inclusion bodies are a site of ebolavirus replication","volume":"86","author":"Hoenen","year":"2012","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"14402","DOI":"10.1073\/pnas.1307681110","article-title":"Live-cell imaging of Marburg virus-infected cells uncovers actin-dependent transport of nucleocapsids over long distances","volume":"110","author":"Schudt","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1093\/infdis\/jiy424","article-title":"A Fluorescently Labeled Marburg Virus Glycoprotein as a New Tool to Study Viral Transport and Assembly","volume":"218","author":"Mittler","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1086\/520590","article-title":"In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein","volume":"196","author":"Ebihara","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17982","DOI":"10.1073\/pnas.0809698105","article-title":"Stimulation of Ebola virus production from persistent infection through activation of the Ras\/MAPK pathway","volume":"105","author":"Strong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Groseth, A., Marzi, A., Hoenen, T., Herwig, A., Gardner, D., Becker, S., Ebihara, H., and Feldmann, H. (2012). The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002847"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wendt, L., Brandt, J., Bodmer, B.S., Reiche, S., Schmidt, M.L., Traeger, S., and Hoenen, T. (2020). The Ebola Virus Nucleoprotein Recruits the Nuclear RNA Export Factor NXF1 into Inclusion Bodies to Facilitate Viral Protein Expression. Cells, 9.","DOI":"10.3390\/cells9010187"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Fu, C., Donovan, W.P., Shikapwashya-Hasser, O., Ye, X., and Cole, R.H. (2014). Hot Fusion: An efficient method to clone multiple DNA fragments as well as inverted repeats without ligase. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0115318"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Shabman, R.S., Hoenen, T., Groseth, A., Jabado, O., Binning, J.M., Amarasinghe, G.K., Feldmann, H., and Basler, C.F. (2013). An upstream open reading frame modulates ebola virus polymerase translation and virus replication. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003147"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4939-6964-7_11","article-title":"Reverse Genetics Systems for Filoviruses","volume":"1602","author":"Hoenen","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bodmer, B.S., Gressler, J., Schmidt, M.L., Holzerland, J., Brandt, J., Braun, S., Groseth, A., and Hoenen, T. (2020). Differences in Viral RNA Synthesis but Not Budding or Entry Contribute to the In Vitro Attenuation of Reston Virus Compared to Ebola Virus. Microorganisms, 8.","DOI":"10.3390\/microorganisms8081215"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2043-9113-2-5","article-title":"Monte Carlo simulation of the Spearman-Kaerber TCID50","volume":"2","author":"Wulff","year":"2012","journal-title":"J. Clin. Bioinform."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41598-017-02460-2","article-title":"Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1099\/0022-1317-82-5-1027","article-title":"The \u2018cleavage\u2019 activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring \u20182A-like\u2019 sequences","volume":"82","author":"Donnelly","year":"2001","journal-title":"J. Gen. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Nelson, E.A., Barnes, A.B., Wiehle, R.D., Fontenot, G.K., Hoenen, T., and White, J.M. (2016). Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications. Viruses, 8.","DOI":"10.3390\/v8080206"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"190ra179","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection","volume":"5","author":"Johansen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10300","DOI":"10.1128\/JVI.79.16.10300-10307.2005","article-title":"Ebola virus VP40 late domains are not essential for viral replication in cell culture","volume":"79","author":"Neumann","year":"2005","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S355","DOI":"10.1093\/infdis\/jiy247","article-title":"Analysis of a Putative Late Domain Using an Ebola Virus Transcription and Replication-Competent Virus-Like Particle System","volume":"218","author":"Wendt","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1128\/JVI.72.11.8756-8764.1998","article-title":"Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes","volume":"72","author":"Muhlberger","year":"1998","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1099\/vir.0.018226-0","article-title":"Establishment and application of an infectious virus-like particle system for Marburg virus","volume":"91","author":"Wenigenrath","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1128\/JVI.80.2.1038-1043.2006","article-title":"Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30","volume":"80","author":"Enterlein","year":"2006","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e00426-18","DOI":"10.1128\/JVI.00426-18","article-title":"Phosphorylated VP30 of Marburg Virus Is a Repressor of Transcription","volume":"92","author":"Tigabu","year":"2018","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2014.03.018","article-title":"High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses","volume":"106","author":"Uebelhoer","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S861","DOI":"10.1093\/infdis\/jir308","article-title":"Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread","volume":"204","author":"Schmidt","year":"2011","journal-title":"J. Infect. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/1044\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:10:38Z","timestamp":1760137838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/1044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["v14051044"],"URL":"https:\/\/doi.org\/10.3390\/v14051044","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]}}}